Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Gilead has based its entire HIV drug portfolio on updating tenofovir, ostensibly to make it safer for bones and kidneys.
Here are the top 20 philanthropic funders of HIV, according to an FCAA report, which also offers good news for the U.S. South and PrEP.
The tablet from the South Korean company Celltrion contains tenofovir disoproxil fumarate and lamivudine.
“This is definitely fantastic news and validates everything science has been saying.”
Truvada drugmaker Gilead Sciences promotes HIV prevention and PrEP.
But how will Cookie deal with her son’s HIV-positive lover?
Researchers have presented 96-week results from an advanced trial of Symtuza compared with Prezcobix plus Truvada.
The LA videos star women of color and promote HIV prevention. Watch all three here!
The study hopes to understand why Black women, who are at higher risk for HIV, are not likely to take PrEP.
The federal initiative aims to help clinicians and their patients understand and access PrEP and PEP.
In clinical trials, the single-tablet regimen of Tivicay (dolutegravir) and Epivir (lamivudine) was as effective as a three-drug treatment.
Highlighting four tools to end HIV
Researchers compared switching to Symtuza with staying on an effective regimen of a boosted protease inhibitor plus Truvada.
Experts emphasize that Truvada for HIV prevention remains highly effective.
This association held true even when researchers controlled for changing rates of viral suppression of HIV in 2012 to 2016 records.
Compared with a regimen based on Prezista, doravirine was better for blood lipids, including cholesterol and triglycerides.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.